Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer

Annals of Nuclear Medicine

Volumn 23, Issue 1, 2009, Pages 73-80

  Okada, Masahiro ^a   Murakami, Takamichi ^a   Kumano, Seishi ^a   Kuwabara, Masatomo ^a   Shimono, Taro ^a   Hosono, Makoto ^a   Shiozaki, Hitoshi ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Contrast enhanced CT; Esophageal cancer; FDG PET CT; Metastatic lymph nodes

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISTANT METASTASIS; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

AGED; CONTRAST MEDIA; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INJECTIONS, INTRAVENOUS; IOPAMIDOL; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; SYSTEMS INTEGRATION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 60349121996     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-008-0209-1     Document Type: Article

References (28)

1. A. Jemal R. Siegel E. Ward T. Murray J. Xu M.J. Thun 2007 Cancer statistics CA Cancer J Clin 57 43 66
2. P. Buenaventura J.D. Luketich 2000 Surgical staging of esophageal cancer Chest Surg Clin N Am 10 487 497
3. K. Sugimachi M. Ikebe K. Kitamura Y. Toh H. Matsuda H. Kuwano 1993 Long-term results of esophagectomy for early esophageal carcinoma Hepatogastroenterology 40 203 206
4. T.W. Rice G. Zuccaro Jr D.J. Adelstein L.A. Rybicki E.H. Blackstone J.R. Goldblum 1998 Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status Ann Thorac Surg 65 787 792
5. D.K. Dhar S. Hattori Y. Tonomoto T. Shimoda H. Kato M. Tachibana 2007 Appraisal of a revised lymph node classification system for esophageal squamous cell cancer Ann Thorac Surg 83 1265 1272
6. J.D. Luketich M. Meehan N.T. Nguyen N. Christie T. Weigel S. Yousem 2000 Minimally invasive surgical staging for esophageal cancer Surg Endosc 14 700 702
7. R.M. Gore 2005 Upper gastrointestinal tract tumours: diagnosis and staging strategies Cancer Imaging 5 95 98
8. K. Ott W. Weber J.R. Siewert 2006 The importance of PET in the diagnosis and response evaluation of esophageal cancer Dis Esophagus 19 433 442
9. F.L. Flanagan F. Dehdashti B.A. Siegel D.D. Trask S.R. Sundaresan G.A. Patterson 1997 Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography AJR Am J Roentgenol 168 417 424
10. H.W. Yeung H.A. Macapinlac M. Mazumdar M. Bains R.D. Finn S.M. Larson 1999 FDG-PET in esophageal cancer: incremental value over computed tomography Clin Positron Imaging 2 255 260
11. C.P. Duong H. Demitriou L. Weih A. Thompson D. Williams R.J. Thomas 2006 Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer Eur J Nucl Med Mol Imaging 33 759 769
12. R. Bar-Shalom L. Guralnik M. Tsalic M. Leiderman A. Frenkel D. Gaitini 2005 The additional value of PET/CT over PET in FDG imaging of oesophageal cancer Eur J Nucl Med Mol Imaging 32 918 924
13. Japanese Society for Esophageal Diseases. Guidelines for the clinical and pathologic studies on carcinoma of the esophagus [in Japanese], 10th ed. Tokyo: Kanehara Shuppan; 2007.
14. J.R. Beck 1986 Likelihood ratios: another enhancement of sensitivity and specificity Arch Pathol Lab Med 110 685 686
15. J.D. Luketich P.R. Schauer C.C. Meltzer R.J. Landreneau G.K. Urso D.W. Townsend 1997 Role of positron emission tomography in staging esophageal cancer Ann Thorac Surg 64 765 769
16. S.C. Rankin H. Taylor G.J. Cook R. Mason 1998 Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma Clin Radiol 53 659 665
17. J.Y. Choi K.H. Lee Y.M. Shim K.S. Lee J.J. Kim S.E. Kim 2000 Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET J Nucl Med 41 808 815
18. Y.C. Yoon K.S. Lee Y.M. Shim B.T. Kim K. Kim T.S. Kim 2003 Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study Radiology 227 764 770
19. H. Kato H. Kuwano M. Nakajima T. Miyazaki M. Yoshikawa H. Ojima 2002 Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma Cancer 94 921 928
20. J.D. Luketich D.M. Friedman T.L. Weigel M.A. Meehan R.J. Keenan D.W. Townsend 1999 Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans Ann Thorac Surg 68 1133 1136
21. T. Lerut P. Flamen N. Ectors E. Van Cutsem M. Peeters M. Hiele 2000 Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy Ann Surg 232 743 752
22. T. Fukunaga S. Okazumi Y. Koide K. Isono K. Imazeki 1998 Evaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose PET J Nucl Med 39 1002 1007
23. H. Kato T. Miyazaki M. Nakajima J. Takita H. Kimura A. Faried 2005 The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma Cancer 103 148 156
24. V.J. Lowe D.M. DeLong J.M. Hoffman R.E. Coleman 1995 Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy J Nucl Med 36 883 887
25. Y. Nakamoto T. Higashi H. Sakahara N. Tamaki M. Kogire R. Doi 2000 Delayed (18)F-fluoro-2-deoxy-D-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas Cancer 89 2547 2554
26. A.R. Boerner M. Weckesser H. Herzog T. Schmitz W. Audretsch U. Nitz 1999 Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer Eur J Nucl Med 26 226 230
27. S. Yamada K. Kubota R. Kubota T. Ido N. Tamahashi 1995 High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue J Nucl Med 36 1301 1306
28. K. Kubota M. Itoh K. Ozaki S. Ono M. Tashiro K. Yamaguchi 2001 Advantage of delayed whole-body FDG-PET imaging for tumour detection Eur J Nucl Med 28 696 703